Gedeon Richter PLC
Gedeon Richter PLC
Your view on GEDSF
Overview
What the company does, where it operates, and who runs it.
About Gedeon Richter PLC
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Gabor Orban
- Headquarters
- GyOemroi Ut 19-21., Budapest, HU
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Gabor Orban
- Headquarters
- GyOemroi Ut 19-21., Budapest, HU
Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale & Retail, and Others. The Pharmaceutical segment engages in research and development, manufacturing, sales and marketing of pharmaceutical products.
The Wholesale & Retail segment represents the distribution of companies and pharmacies that are part of the sales network in various regional markets and, as such, convey its products to consumers. The Other segment relates to the business of the members of the group that provide marketing and sales support services.
The company was founded by Gedeon Richter in 1901 and is headquartered in Budapest, Hungary.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Gedeon Richter PLC, and the rating behind it. GEDSF last traded at $24.85, 10.0× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Gedeon Richter PLC. Starting points for Gedeon Richter PLC: P/E 10.0, EPS $1258.18, beta 0.24 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Gedeon Richter PLC. Gedeon Richter PLC does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Gedeon Richter PLC. Trailing twelve-month EPS for Gedeon Richter PLC stands at $1258.18. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Gedeon Richter PLC. Gedeon Richter PLC has reported as a listed company since 2000. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Gedeon Richter PLC valued side by side against its closest peers. Gedeon Richter PLC is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Gedeon Richter PLC, and how their positions are changing. At a $4.54B market value, institutional positions materially move Gedeon Richter PLC's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Gedeon Richter PLC executives and directors. Shares of Gedeon Richter PLC have traded between $24.85 and $24.85 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Gedeon Richter PLC. Gedeon Richter PLC is a $4.54B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Gedeon Richter PLC. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Gedeon Richter PLC. Coverage tracks Gedeon Richter PLC within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.